Last update 05 Apr 2025

Recombinant human epidermal growth factor(Kyung Hee University)

Overview

Basic Info

Drug Type
Growth factors
Synonyms-
Target
EGFR
Action
agonists
Mechanism
EGFR agonists(Epidermal growth factor receptor erbB1 agonists)
Therapeutic Areas
Skin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Dermatitis
Originator Organization
Kyung Hee University
Active Organization-
Inactive Organization
Kyung Hee University
Drug Highest PhaseDiscontinuedClinical
First Approval Date-
Regulation-

Related

2
Clinical Trials associated with Recombinant human epidermal growth factor(Kyung Hee University)
ChiCTR1800015322
/ SuspendedNot ApplicableIIT
Research of Silver Sulfadiazine-impregnated Hydrocolloid Dressing And Recombinant Human Epidermal Growth Factor on Superficial Second-degree burns
TCTR20171004003
/ Not yet recruitingNot ApplicableIIT
A prospective randomized control trial comparing the effect of Chloramphenicol ointment with Recombinant Human Epidermal Growth Factor on secon degree facial burn wound healing
100 Clinical Results associated with Recombinant human epidermal growth factor(Kyung Hee University)
Login to view more data
100 Translational Medicine associated with Recombinant human epidermal growth factor(Kyung Hee University)
Login to view more data
100 Patents (Medical) associated with Recombinant human epidermal growth factor(Kyung Hee University)
Login to view more data
100 Deals associated with Recombinant human epidermal growth factor(Kyung Hee University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DermatitisClinical-
Kyung Hee University
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free
By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and improve user experiences.